Emergent BioSolutions | Los Gastos De Explotación

Operating Expenses Cambio Fecha
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
ALKERMES USD 337.09M 41.11M 2023-09
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
ANI Pharmaceuticals USD 124.93M 11.05M 2023-12
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Exact Sciences USD 714.73M 93.24M 2023-12
Exelixis USD 489.5M 97.5M 2023-09
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Ironwood Pharmaceuticals USD 79.96M 6.25M 2023-12
Lonza CHF 2.54B 193M 2023-06
Merck USD 16.56B 6.35B 2023-12
Moderna USD 2.8B 1.04B 2023-12
Myriad Genetics USD 228M 24M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
Pacira USD 148.08M 1.87M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
PTC Therapeutics USD 438.79M 124.05M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
United Therapeutics USD 354.6M 72.2M 2023-12



Emergent BioSolutions Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.